This report analyzes trends in global demand for in vitro diagnostic (IVD) products used in physicians’ office laboratories. Specific products consist of reagents, test kits, standards and controls, and instruments and systems based on immunoassay, clinical chemistry, hematology, molecular, microbiology, and coagulation technologies. Physicians’ office laboratories are defined as point-of-care (POC) testing sites within traditional practices or urgent care centers staffed by one or more physicians. Most of these laboratories implement IVD procedures through one or more portable desktop instruments that yield rapid diagnostic results.
Information and data appearing in this report include:
- Macroeconomic, demographic, epidemiological, and healthcare indicators that influence product demand patterns and growth opportunities
- Projected global product demand by type and technology for the years 2022 through 2027
- The projected value of regional and selected national markets for physicians’ office laboratory IVD products in each of the forecast years (2022 through 2027).
The report also includes profiles of the major producers of physicians’ office laboratory IVD products.
Report coverage extends to worldwide markets, but focuses on the United States and other developed countries. The majority of physicians’ practices in the developing world are located in hospitals and outpatient clinics and do not engage actively in patient testing.
In addition, the report profiles key companies in the market, including:
- Abbott Laboratories
- Abingdon Health
- ACON Laboratories, Inc.
- ArcDia International Oy Ltd.
- Axis-Shield Diagnostics Ltd.
- Becton Dickinson and Company (BD)
- binx health, inc.
- Bio-Rad Laboratories, Inc.
- Biocartis NV
- Biomerica, Inc
Table of Contents
Chapter 1: Introduction
- Scope & Report Coverage
- Methodology
- Sources of Information
Chapter 2: Executive Summary
- Physicians’ Office Laboratories: Market Overview
- Product Demand Patterns
- Geographical Markets
- Size and Growth of the Market
- Table 2-1: Summary Table: Global Physicians’ Office Laboratory Market, 2022-2027 (Million Dollars)
Chapter 3: Market Environment
- Overview
- Global Economic Outlook
- Gross Domestic Product
- Table 3-1: Gross Domestic Product by Country/Region, 2022-2027 (Billion Dollars)
- Per Capita Gross Domestic Product
- Table 3-2: Per Capita Gross Domestic Product by Country/Region, 2022-2027 (Dollars)
- Population
- Table 3-3: Population by Country/Region, 2022-2027 (Million Persons)
- Age Distribution
- Population 50 Years & Older
- Table 3-4: Population 50 Years & Older by Country/Region, 2022-2027 (Million Persons)
- Table 3-5: Percentage of Population 50 Years & Older by Country/Region, 2022-2027 (Million Persons)
- Population 65 Years & Older
- Table 3-6: Population 65 Years & Older by Country/Region, 2022-2027 (Million Persons)
- Table 3-7: Percentage of Population 65 Years & Older by Country/Region, 2022-2027 (Million Persons)
- Global Healthcare Trends
- Medical Conditions
- Health Expenditures
- Table 3-8: Health Expenditures by Country/Region, 2022-2027 (Billion Dollars)
- Table 3-9: Per Capita Health Expenditures by Country/Region, 2022-2027 (Dollars)
- Hospital Beds
- Table 3-10: Number of Acute Care Hospital Beds by Country/Region, 2022-2027 (Thousands)
- Table 3-11: Number of Hospital Beds Per 1,000 Capita by Country/Region, 2022-2027
- Physicians
- Table 3-12: Number of Practicing Physicians by Country/Region, 2022-2027 (Thousands)
- Table 3-13: Number of Practicing Physicians Per 1,000 Capita by Country/Region, 2022-2027
- Patient Activity
- Acute Care Hospital Admissions
- Table 3-14: Number of Acute Care Hospital Admissions by Country/Region, 2022-2027 (Thousands)
- Table 3-15: Number of Acute Care Hospital Admissions Per 1,000 Capita by Country/Region, 2022-2027
- Surgical Procedures
- Table 3-16: Number of Surgical Procedures by Country/Region, 2022-2027 (Thousands)
- Table 3-17: Number of Surgical Procedures Per 1,000 Capita by Country/Region, 2022-2027
- Physicians’ Consultations
- Table 3-18: Number of Physicians’ Consultations by Country/Region, 2022-2027 (Millions)
- Table 3-19: Number of Physicians’ Consultations Per Capita by Country/Region, 2022-2027
- IVD Tests
- Table 3-20: Number of IVD Tests by Country/Region, 2022-2027 (Millions)
- Table 3-21: Number of IVD Tests Per Capita by Country/Region, 2022-2027
- Traditional Physicians’ Offices
- Table 3-22: Number of Traditional Physicians’ Offices by Country/Region, 2022-2027 (Thousands)
- Urgent Care Centers
- Table 3-23: Number of Urgent Care Centers by Country/Region, 2022-2027
- Physicians’ Office Laboratories
- Table 3-24: Number of Physicians’ Office Laboratories by Country/Region, 2022-2027 (Thousands)
Chapter 4: Physicians’ Office Laboratory (Pol) IVD Products
- Overview
- IVD Industry Trends
- Table 4-1: Global IVD Product Demand by Technology & Segment, 2022-2027 (Million Dollars)
- IVD Technologies
- Immunoassays
- Clinical Chemistry
- Molecular IVD Technology
- Microbiology
- Hematology
- Coagulation
- Histology/Cytology
- Blood Grouping
- Other IVD Technologies
- Industry Regulations
- Point-Of-Care (Poc) Testing Market
- Table 4-2: Global Point-Of-Care IVD Product Sales, 2022-2027 (Million Dollars)
- Physicians’ Office Poc Testing: Market Overview
- Table 4-3: Global Physicians’ Office Laboratory Total IVD Sales (With Covid-19 Products) by Type of Establishment, 2022-2027 (Million Dollars)
- Table 4-4: Global Physicians’ Office Laboratory Total IVD Sales (Excluding Covid-19 Products) by Type of Establishment, 2022-2027 (Million Dollars)
- Pol Testing Applications
- Table 4-5: Total Physicians’ Office Laboratory Global IVD Sales by Application, 2022-2027 (Million Dollars)
- Table 4-6: Traditional Physicians’ Office Laboratories Global IVD Sales by Application, 2022-2027 (Million Dollars)
- Table 4-7: Urgent Care Center Laboratories Global IVD Sales by Application, 2022-2027 (Million Dollars)
- Infectious Disease Pol Tests
- Covid-19 Pol Tests
- Table 4-8: Global Pol Covid-19 IVD Product Sales, 2022-2027 (Million Dollars)
- Other Infectious Disease Pol Tests
- Table 4-9: Global Pol Other Infectious Disease IVD Product Sales, 2022-2027 (Million Dollars)
- Colon Cancer Pol Tests
- Table 4-10: Global Pol Colon Cancer IVD Product Sales, 2022-2027 (Million Dollars)
- Glucose Pol Tests
- Table 4-11: Global Pol Glucose IVD Product Sales, 2022-2027 (Million Dollars)
- Drugs of Abuse Pol Tests
- Table 4-12: Global Pol Drugs of Abuse IVD Product Sales, 2022-2027 (Million Dollars)
- Blood Gas & Electrolyte Pol Tests
- Table 4-13: Global Pol Blood Gas & Electrolyte IVD Product Sales, 2022-2027 (Million Dollars)
- Coagulation Pol Tests
- Table 4-14: Global Pol Coagulation IVD Product Sales, 2022-2027 (Million Dollars)
- Cardiac Marker Pol Tests
- Table 4-15: Global Pol Cardiac Marker IVD Product Sales, 2022-2027 (Million Dollars)
- Hematology Pol Tests
- Table 4-16: Global Pol Hematology IVD Product Sales, 2022-2027 (Million Dollars)
- Hba1C Pol Tests
- Table 4-17: Global Pol Hba1C IVD Product Sales, 2022-2027 (Million Dollars)
- Cholesterol Pol Tests
- Table 4-18: Global Pol Cholesterol IVD Product Sales, 2022-2027 (Million Dollars)
- Pregnancy/Infertility Pol Tests
- Table 4-19: Global Pol Pregnancy/Infertility IVD Product Sales, 2022-2027 (Million Dollars)
- Cancer Marker Pol Tests
- Table 4-20: Global Pol Cancer Marker IVD Product Sales, 2022-2027 (Million Dollars)
- Urinalysis Pol Tests
- Table 4-21: Global Pol Urinalysis IVD Product Sales, 2022-2027 (Million Dollars)
- Other Pol Tests
- Table 4-22: Global Pol Other IVD Product Sales, 2022-2027 (Million Dollars)
- Pol IVD Product Sales by Type
- Table 4-24: Global Pol IVD Product Sales by Type, 2022-2027 (Million Dollars)
Chapter 5: Geographical Markets
- Overview
- Table 4-24: Global Pol IVD Product Sales by Type, 2022-2027 (Million Dollars)
- United States
- Canada
- Mexico
- Germany
- France
- United Kingdom
- Italy
- Spain
- Other Western Europe
- China
- India
- Japan
- South Korea
- Australia
- Other Asia/Pacific
- Central & South America
- Eastern Europe
- Africa/Mideast
Chapter 6: Company Profiles
- Overview
- Table 6-1: Global Pol Testing Revenues and Market Share of Leading Suppliers, 2022 (In Millions $)
- Abbott Laboratories
- Abingdon Health
- Acon Laboratories, Inc.
- Arcdia International Oy Ltd.
- Axis-Shield Diagnostics Ltd.
- Becton Dickinson and Company (Bd)
- Binx Health, Inc.
- Bio-Rad Laboratories, Inc.
- Biocartis Nv
- Biomerica, Inc.
- Biomérieux S.A.
- Boule Diagnostics Ab
- Cardinal Health, Inc.
- Carolina Liquid Chemistries Corporation
- Chembio Diagnostics, Inc.
- Danaher Corporation
- Diasorin S.P.A.
- Diasys Diagnostic Systems GmbH
- Diazyme Laboratories, Inc.
- Ekf Diagnostics Holdings plc
- Exact Sciences Corporation
- Genedrive plc
- Horiba Ltd.
- Immunostics, Inc.
- Medmira, Inc.
- Meridian Bioscience, Inc.
- Orasure Technologies
- Pts Diagnostics
- Quantumdx Group Ltd.
- Quidelortho Corporation
- Roche
- Siemens Healthcare GmbH (Siemens Healthineers)
- Stago Group
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Trinity Biotech plc
- Werfen
Companies Mentioned
- Abbott Laboratories
- Abingdon Health
- Acon Laboratories, Inc.
- Arcdia International Oy Ltd.
- Axis-Shield Diagnostics Ltd.
- Becton Dickinson and Company (Bd)
- Binx Health, Inc.
- Bio-Rad Laboratories, Inc.
- Biocartis Nv
- Biomerica, Inc.
- Biomérieux S.A.
- Boule Diagnostics Ab
- Cardinal Health, Inc.
- Carolina Liquid Chemistries Corporation
- Chembio Diagnostics, Inc.
- Danaher Corporation
- Diasorin S.P.A.
- Diasys Diagnostic Systems GmbH
- Diazyme Laboratories, Inc.
- Ekf Diagnostics Holdings plc
- Exact Sciences Corporation
- Genedrive plc
- Horiba Ltd.
- Immunostics, Inc.
- Medmira, Inc.
- Meridian Bioscience, Inc.
- Orasure Technologies
- Pts Diagnostics
- Quantumdx Group Ltd.
- Quidelortho Corporation
- Roche
- Siemens Healthcare GmbH (Siemens Healthineers)
- Stago Group
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Trinity Biotech plc
- Werfen
